106 related articles for article (PubMed ID: 6173369)
21. Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
Sugimoto Y; Suzuki H; Yamaki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1982 Sep; 35(9):1222-30. PubMed ID: 7142023
[TBL] [Abstract][Full Text] [Related]
22. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
23. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system.
Umezawa K; Haresaku M; Muramatsu M; Matsushima T
Biomed Pharmacother; 1987; 41(5):214-8. PubMed ID: 2444280
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
Fujimoto S; Inagaki J; Horikoshi N; Ogawa M
Gan; 1979 Aug; 70(4):411-20. PubMed ID: 92432
[TBL] [Abstract][Full Text] [Related]
25. Studies on the cytotoxicity, mutagenicity and chromosomal aberration-inducing activity of aclacinomycin A in cultured mammalian cells.
Shuin T; Moriyama M; Nishimura R; Takai S; Umeda M
Gan; 1981 Apr; 72(2):197-204. PubMed ID: 6169583
[TBL] [Abstract][Full Text] [Related]
26. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
Gutierrez PL; Wilder PJ; Biswal N
Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
[TBL] [Abstract][Full Text] [Related]
27. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
[No Abstract] [Full Text] [Related]
28. Anthracycline resistance and consequences of the in situ-in vitro transfer.
Sonka J; Stöhr M; Vogt-Schaden M; Volm M
Cytometry; 1985 Sep; 6(5):437-44. PubMed ID: 3862514
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
30. Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells.
Tarasiuk J; Garnier-Suillerot A
Eur J Biochem; 1992 Mar; 204(2):693-8. PubMed ID: 1541282
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
Skovsgaard T
Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
[No Abstract] [Full Text] [Related]
32. Ouabain-resistant (Na+,K+)-ATPase enzyme activity in chemically induced ouabain-resistant C3H/10T1/2 cells.
Shibuya ML; Miura T; Lillehaug JR; Farley RA; Landolph JR
Mol Toxicol; 1989; 2(2):75-98. PubMed ID: 2562032
[TBL] [Abstract][Full Text] [Related]
33. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
34. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
[TBL] [Abstract][Full Text] [Related]
35. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
36. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
37. Isolation of plasma membranes from the bovine retinal pigment epithelium.
Braunagel SC; Organisciak DT; Wang HM
Biochim Biophys Acta; 1985 Mar; 813(2):183-94. PubMed ID: 2982402
[TBL] [Abstract][Full Text] [Related]
38. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A.
Schaefer A; Boldt J; Westendorf J; Steinheider G; Marquardt H
Biochem Pharmacol; 1988 Apr; 37(7):1377-82. PubMed ID: 3162677
[TBL] [Abstract][Full Text] [Related]
40. Protein and enzyme content of plasma membranes derived from Walker 256 carcinoma cells grown as ascitic or solid tumours.
Clark CM; Goodlad GA
Cancer Lett; 1993 Feb; 68(2-3):91-4. PubMed ID: 8383003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
